The Association of Gut Microbiota With COVID 19 Infection in Children

Status Recruiting

Clinical Trial Summary

Although COVID-19 infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. The investigators will analyze the alterations in fecal microbiomes of patients with COVID-19 infection during hospitalization.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Childhood ALL
Communicable Diseases
Coronavirus Infections
Gut Microbiome
Infections
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trial Details

NCT number	NCT05303155
Study type	Observational
Source	Hallym University Kangnam Sacred Heart Hospital
Contact	KY YOUNG CHO, MD, PhD
Phone	821090910197
Email	choky96@naver.com
Status	Recruiting
Phase
Start date	April 14, 2022
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04553575` - CoViD-19 Patient in Reims University Hospital in March to April 2020
Active, not recruiting	`NCT05033847` - Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above	Phase 2
Active, not recruiting	`NCT05548439` - Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a	Phase 1
Completed	`NCT05046548` - This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19	Phase 1/Phase 2
Active, not recruiting	`NCT05726084` - Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older	Phase 2/Phase 3
Recruiting	`NCT05069129` - Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above	Phase 1/Phase 2
Enrolling by invitation	`NCT05054075` - Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19	Phase 2
Recruiting	`NCT05599516` - Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial	Phase 3
Completed	`NCT05047900` - The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community	N/A
Completed	`NCT04420286` - Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France
Completed	`NCT04424355` - Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.
Completed	`NCT05083039` - Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19
Terminated	`NCT04409873` - Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)	Phase 2
Enrolling by invitation	`NCT04327349` - Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial	N/A
Completed	`NCT04321278` - Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)	Phase 3
Recruiting	`NCT04327570` - In-depth Immunological Investigation of COVID-19.
Completed	`NCT04326309` - Audio Data Collection for Identification and Classification of Coughing
Recruiting	`NCT04322344` - Escin in Patients With Covid-19 Infection	Phase 2/Phase 3
Completed	`NCT04328129` - Household Transmission Investigation Study for COVID-19 in Tropical Regions	N/A
Completed	`NCT04323592` - Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome